Literature DB >> 27254104

Special considerations in pregnant systemic sclerosis patients.

Vincent Sobanski1,2,3,4, David Launay1,2,3,4, Sandrine Depret5, Anne-Sophie Ducloy-Bouthors6, Eric Hachulla1,2,3,4.   

Abstract

INTRODUCTION: Evaluating the fertility and pregnancy outcomes in systemic sclerosis (SSc) women is challenging. Studies are still limited or subject to potential methodological biases. Areas covered: This work is a comprehensive review of the literature. We discuss the potential impact of SSc on women's pregnancy outcomes and the effects of pregnancy on SSc. We summarize the physiological changes during pregnancy and describe our experience. Expert commentary: Although the miscarriage rate does not appear increased in SSc, women are exposed to a higher risk of premature birth and intrauterine growth restriction compared with the general population. Early diffuse cutaneous SSc and use of corticosteroids are risk factors, whereas folic acid use prevents against premature birth. All SSc women wishing to conceive should be counselled during a preconception visit. Physiological changes arising during pregnancy may be the source of clinical problems in SSc women with organs with limited capacities.

Entities:  

Keywords:  Systemic sclerosis; connective tissue disease; hypertension; miscarriage; placenta; preeclampsia; pregnancy; prematurity; renal crisis; scleroderma

Mesh:

Year:  2016        PMID: 27254104     DOI: 10.1080/1744666X.2016.1194201

Source DB:  PubMed          Journal:  Expert Rev Clin Immunol        ISSN: 1744-666X            Impact factor:   4.473


  6 in total

1.  French recommendations for the management of systemic sclerosis.

Authors:  Eric Hachulla; Christian Agard; Yannick Allanore; Jerome Avouac; Brigitte Bader-Meunier; Alexandre Belot; Alice Berezne; Anne-Sophie Bouthors; Geraldine Condette-Wojtasik; Joël Constans; Pascal De Groote; Elisabeth Diot; Florence Dumas; Patrick Jego; Francisca Joly; David Launay; Veronique Le Guern; Janine-Sophie Le Quintrec; Geraldine Lescaille; Christophe Meune; Bruno Moulin; Christelle Nguyen; Nadine Omeish; Frederic Pene; Marie-Aleth Richard; Juliette Rochefort; Alexandra Roren; Olivier Sitbon; Vincent Sobanski; Marie-Elise Truchetet; Luc Mouthon
Journal:  Orphanet J Rare Dis       Date:  2021-07-26       Impact factor: 4.123

Review 2.  Rheumatic Diseases in Reproductive Age-the Possibilities and the Risks.

Authors:  Bogna Grygiel-Górniak; Elena Masiero; Briana Candace Nevaneeth; Melissa Mary Jojy
Journal:  Reprod Sci       Date:  2022-03-31       Impact factor: 3.060

Review 3.  Reproductive Issues and Pregnancy Implications in Systemic Sclerosis.

Authors:  Maria-Grazia Lazzaroni; Francesca Crisafulli; Liala Moschetti; Paolo Semeraro; Ana-Rita Cunha; Agna Neto; Andrea Lojacono; Francesca Ramazzotto; Cristina Zanardini; Sonia Zatti; Paolo Airò; Angela Tincani; Franco Franceschini; Laura Andreoli
Journal:  Clin Rev Allergy Immunol       Date:  2022-01-18       Impact factor: 8.667

Review 4.  Pregnancy in Chronic Kidney Disease: Need for Higher Awareness. A Pragmatic Review Focused on What Could Be Improved in the Different CKD Stages and Phases.

Authors:  Giorgina B Piccoli; Elena Zakharova; Rossella Attini; Margarita Ibarra Hernandez; Alejandra Orozco Guillien; Mona Alrukhaimi; Zhi-Hong Liu; Gloria Ashuntantang; Bianca Covella; Gianfranca Cabiddu; Philip Kam Tao Li; Guillermo Garcia-Garcia; Adeera Levin
Journal:  J Clin Med       Date:  2018-11-05       Impact factor: 4.241

5.  Clinical and serological characteristics of systemic sclerosis: Experience of a tertiary care center in Pakistan.

Authors:  Sadia Asif; Asadullah Khan; Muhammad Faiq; Zia Ud Din; Sarmad Zahoor; Muhammad Haroon
Journal:  Arch Rheumatol       Date:  2021-10-24       Impact factor: 1.472

6.  Systemic sclerosis and pregnancy outcomes: a retrospective study from a single center.

Authors:  Giuseppe Barilaro; Aleida Castellanos; Inês Gomez-Ferreira; Gema Maria Lledó; Carlo Della Rocca; Lorena Fernandez-Blanco; Ricard Cervera; Núria Baños; Francesc Figueras; Gerard Espinosa
Journal:  Arthritis Res Ther       Date:  2022-04-27       Impact factor: 5.606

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.